SCHEMBL3671760

SCHEMBL3671760

CC1(C)OB(c2ccc3c(c2)cc(C(=O)O)n3C(=O)O)OC1(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 9/20 0.38
LPL P06858 8/20 0.38
P4HB P07237 1/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MCL1 Q07820 1/20 0.37
F2 P00734 2/20 0.36
F11 P03951 2/20 0.36
PRSS1 P07477 2/20 0.36
PRSS2 P07478 2/20 0.36
PRSS3 P35030 2/20 0.36
ROCK1 Q13464 1/20 0.36
LDHA P00338 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
DAO P14920 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3642532 0.90 IRAK4 (0.40) LIPGLPLP4HBALDH1A1MCL1
SCHEMBL1565096 0.85 USP30 (0.39) F2F11PRSS1PRSS2PRSS3
SCHEMBL20618017 0.77 MCL1 (0.50) LIPGLPLP4HBKDM4EALDH1A1
SCHEMBL2461405 0.76 LIPG (0.40) LIPGLPLP4HBF2F11
SCHEMBL24944308 0.75 USP30 (0.39) LIPGLPLF2F11PRSS1
SCHEMBL20740520 0.74 ROCK1 (0.35) LIPGLPLP4HBF2F11
SCHEMBL13310649 0.74 L3MBTL1 (0.58) P4HBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL15642678 0.74 CCR2 (0.65)
SCHEMBL5473161 0.74 IRAK4 (0.46) LIPGLPLP4HBF2F11
SCHEMBL13348212 0.73 USP30 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176256-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES AstraZeneca AB (SE) 2010-04-21 EP disclosed
WO-2009007751-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed